Mary Lou CookTissue Studies of Human Eye DiseasesA Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)Polarization Perception in Health and Disease. Testing a New Sight TestPharmacokinetic and Pharmacodynamic Study of Emixustat in Subjects With Geographic Atrophy Associated With Dry Age-Related Macular DegenerationA Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD PatientsPhase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular DegenerationClinical and Genetic Analyzes of Age-related Macular DegenerationComparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical TrialThe Effects of Bevacizumab and Ranibizumab on Ocular Pulse Amplitude in Neovascular Age Related Macular Degeneration (AMD)Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)The Role of Macular Pigment in Patients With Age-related Macular DegenerationReduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)Effects of Sun Filters on Age-related Macular Degeneration in People With Lens ImplantsThe OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD)Study of Treatment Effects of Combination Therapy of Lucentis Plus Reduced Fluence PDT With Visudyne in Patients With Exudative AMDA Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular DegenerationStudy Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNVStudy of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular DegenerationCombination Bevacizumab and Verteporfin (Two Different Sequences of Treatment)in Neovascular AMDLucentis Utilizing Visudyne (LUV Trial) Combination Therapy in the Treatment of Age-Related Macular DegenerationAge-related Macular Degeneration: Detection of Onset of New Choroidal Neovascularization (AMD DOC Study)A Study of an Encapsulated Cell Technology (ECT) Implant for Patients With Atrophic Macular DegenerationCombination Therapy for Neovascular Age Related Macular DegenerationSafety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMDInfluence of Blue Light Filtering Intraocular Lenses on Daytime Levels of MelatoninRheohemapheresis and Lutein Supplementation in the Non-Exsudative Form of Age-Related Macular DegenerationAn OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMDCombined PDT and Intravitreal Bevacizumab vs Combination of PDT, Intravitreal Bevacizumab and Triamcinolone for Neovascular AMDIntravitreal Bevacizumab vs. Bevacizumab Combined With Triamcinolone for Neovascular AMDA Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)HOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome DeviceComparison Between Foresee Home and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)A Safety Study to Evaluate Pazopanib Eye Drops in Healthy VolunteersAnalysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular DegenerationSafety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)Study EvAluating Genotypes While Using Lucentis 2Genetic Assessment of Early to Late Macular Degeneration StudyFUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration
P1050
Q10327039-8826cc0d-42fc-cbc6-0055-5d41767acb5fQ61694815-02C7373D-D910-45F3-82A7-B86DFC4C5891Q61727955-FEED818F-DE00-47EB-A28F-69F0BC97E0E7Q61727957-BC2D34F1-C165-4206-8DDA-44A66B2AED75Q61727971-F85B88B4-6512-4598-A9AE-C0436D0E95B7Q61894393-4567AA35-7BA6-4D29-9298-77602E195993Q61894429-EBF6F888-FD9C-4BDE-BB14-A8DBF607F8C7Q61894634-BD3FBF33-34FF-4268-BE07-627B94B3ED4DQ61904997-0171082E-F824-4C46-B820-07CA356AB6B5Q61906973-7FA8BB69-4513-4470-9A1E-F8BA4908753FQ61914904-034AB676-E4AB-4E1C-9552-99EE83FFE096Q61915247-EFFDE713-4214-47C5-9A86-197E49A283E3Q61917712-FB462CEC-00D0-4EBF-ABDD-94BA5DEAAE12Q61917901-398B1113-AA60-46A3-903E-ECE2AAA6BAB2Q61918292-081E553D-CEC0-48BA-BB7A-A1A486C18C6DQ61918514-731253B2-C379-45C6-A5B1-BE28571A4944Q61920596-5284E11D-7083-4C4D-99E6-CAFB16CFE374Q61920719-FD1300EE-601C-43B5-810E-2CD1CEBF2797Q61921143-04F6E683-D9D5-461D-B926-1A9D1D1B5857Q61921146-B86E10C8-97D9-48EE-A1A2-26BE02FC4839Q61921388-78F94B1C-0FBD-466E-98FC-8E23B97A4C50Q61921708-91810EED-1766-4689-930E-359C836B9619Q61922256-36CB5982-4E20-4834-A4CC-E7C56F638D3AQ61924253-1C9E1981-F005-4C12-8E4D-30E4C35ED99AQ61924362-7019ED2B-038E-435E-98BD-C83DEB5B9217Q61924404-DDEA313A-6FAD-4321-AA48-951D02FC676BQ61924768-573670F3-8E1D-42AB-A5BF-318C65BCE8C0Q61924810-25D8A02A-DE7A-480D-A9A9-CF6AB72CD955Q61932733-A22338AB-6A7D-4393-B8EE-B2ADBE98ED34Q61933311-3C8EC704-1A4A-4F40-BA4D-D660AF413F40Q61933336-1A521888-9C2F-4DB5-886F-77BCF60903F0Q61934640-2F0F088E-30A7-41EB-AF1F-3158D7F320F6Q61935787-1B47B2BF-F02C-491D-B1DD-5CB0C13EBC37Q61938440-0EB402B9-40F3-4FBA-8067-A08444CD836EQ61938590-F180E784-587E-4859-A1D5-80F52703A6B3Q61955366-F1C6A845-6E13-4C1F-B67F-F4BA58AFD553Q61955722-499A8C83-FB64-447A-9301-223B881EA8FCQ61956683-BE5E694C-CBA2-43B4-91A6-8E0126BC328FQ61956685-B45206C1-A2A2-4D5A-B59A-D659D96E5C91Q61957646-8DB84A82-9221-499F-BAF7-E041004512D2
P1050
description
A retinal degeneration charact ...... symptoms include vision loss.
@en
Krankheit
@de
name
Degeneração macular
@pt
degeneració macular
@ca
degeneración macular
@es
dégénérescence maculaire
@fr
macular degeneration
@en
makuladegenerasjon
@nn
type
label
Degeneração macular
@pt
degeneració macular
@ca
degeneración macular
@es
dégénérescence maculaire
@fr
macular degeneration
@en
makuladegenerasjon
@nn
altLabel
Macular degeneration of retina
@en
prefLabel
Degeneração macular
@pt
degeneració macular
@ca
degeneración macular
@es
dégénérescence maculaire
@fr
macular degeneration
@en
makuladegenerasjon
@nn
P279
P7033
P1417
science/macular-degeneration